Accelerate Diagnostics, Inc. Stock
Equities
AXDX
US00430H2013
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9301 USD | -1.61% | +8.28% | -76.27% |
Financials (USD)
Sales 2024 * | 12.17M | Sales 2025 * | 14.48M | Capitalization | 20.15M |
---|---|---|---|---|---|
Net income 2024 * | -49M | Net income 2025 * | -44M | EV / Sales 2024 * | 1.66 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.39 x |
P/E ratio 2024 * |
-0.41
x | P/E ratio 2025 * |
-0.48
x | Employees | 134 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 62.89% |
Latest transcript on Accelerate Diagnostics, Inc.
1 day | -1.61% | ||
1 week | +8.28% | ||
Current month | -6.05% | ||
1 month | -3.14% | ||
3 months | -27.34% | ||
6 months | -84.70% | ||
Current year | -76.27% |
Managers | Title | Age | Since |
---|---|---|---|
Jack Phillips
CEO | Chief Executive Officer | 58 | 19-07-31 |
David Patience
DFI | Director of Finance/CFO | 38 | 17-08-31 |
Maya Gowri
COO | Chief Operating Officer | - | 22-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Patience
BRD | Director/Board Member | 76 | 12-06-25 |
Jack Schuler
BRD | Director/Board Member | 83 | 12-06-25 |
Director/Board Member | 71 | 19-12-01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 509 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.9301 | -1.61% | 4,924 |
24-04-25 | 0.9453 | +1.54% | 14,119 |
24-04-24 | 0.931 | -2.00% | 12,785 |
24-04-23 | 0.95 | +7.05% | 137,870 |
24-04-22 | 0.8874 | +3.31% | 18,342 |
Delayed Quote Nasdaq, April 26, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-76.27% | 20.15M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- AXDX Stock